Cannabis use in early adolescence was linked to more depressive symptoms, and teens who used cannabis and had smaller amygdala volumes were at particularly elevated risk.
Researchers studying adolescent brain development and cannabis; mental health professionals working with teens.
Cannabis-using teens with smaller amygdala volumes had significantly more depressive symptoms (p < 0.01)
What the researchers found
Cannabis use was not associated with amygdala volume differences but was associated with increased depressive symptoms. An interaction effect showed that cannabis-using teens with smaller amygdala volumes had significantly more depressive symptoms than those with larger volumes.
Why it matters
This study suggests that not all teen cannabis users face the same mental health risks. Brain structure -- specifically amygdala size -- may identify which young cannabis users are most vulnerable to depression, pointing toward a biological basis for individual differences in cannabis-related mental health outcomes.
The numbers in context
Cannabis users had significantly more depressive symptoms than non-users (p < 0.01). Cannabis group interacted with amygdala volume to predict depression (p values ranging from < 0.01 to 0.02). Cannabis use alone was not significantly associated with amygdala volume.
How the study worked
Cross-sectional analysis of 224 participants (ages 12-15) from the ABCD Study, balanced by sex. Cannabis users were identified through hair toxicology and self-report, then demographically matched to non-users. Depression symptoms were measured via the Child Behavioral Checklist. Linear mixed effect models examined cannabis group, amygdala volume, and their interaction.
What this study cannot tell us
Cross-sectional design cannot determine whether smaller amygdala volumes preceded cannabis use or whether cannabis use contributed to volume differences over time. Parent-reported depression measures may not fully capture teens' internal experiences.
How to read the evidence
Moderate: uses objective hair toxicology and brain imaging from a large national study, but cross-sectional design limits causal interpretation.
When this study was published
2024 study using ABCD Study data.
The bigger picture
The amygdala plays a central role in emotion processing. Finding that its size moderates the cannabis-depression link in teens suggests pre-existing brain differences may determine who is most affected by early cannabis use, which could eventually inform targeted screening.
Questions still open
- Does amygdala volume change over time in adolescent cannabis users? Could amygdala size measured before cannabis initiation predict which teens will develop depression after starting to use?
Common questions
Did cannabis shrink the amygdala?
What is the amygdala's role in depression?
Read the original research
Amygdala volume and depression symptoms in young adolescents who use cannabis.
Behavioural brain research, 472, 115150
Citation
Wallace, Alexander L; Huestis, Marilyn A; Sullivan, Ryan M; Wade, Natasha E. (2024). Amygdala volume and depression symptoms in young adolescents who use cannabis.. Behavioural brain research, 472, 115150. https://doi.org/10.1016/j.bbr.2024.115150
Explore the wider topic
- LGBTQ+ and Cannabis: Higher Use Rates and Recovery
- Cannabis-Induced Psychosis: What It Is, Who's at Risk, and What to Do
- BetterHelp, Cerebral, and Online Therapy: Honest Review
- Quitting Weed with ADHD: Why It Is Harder and What Actually Helps
- Quitting Weed with Depression: What You Need to Know
- Quitting Weed with PTSD: A Practical Guide
- Self-Medicating with Weed: Why It Works Until It Doesn't
- Weed and OCD: Self-Medicating Intrusive Thoughts
- Weed and PTSD: What the Research Actually Shows
- Weed and Childhood Trauma: ACEs, Self-Medication, and the Path to Real Healing
- Weed and Suicidal Thoughts: What You Need to Know